Literature DB >> 20127274

Id2 deficiency promotes metastasis in a mouse model of ocular cancer.

Olga A Agapova1, Erica Person, J William Harbour.   

Abstract

The inhibitor of DNA binding 2 (Id2) basic helix-loop-helix protein interacts genetically and physically with the pocket proteins (Rb, p107 and p130) and has been implicated as an oncogene. In other studies, however, Id2 has been shown to function as a tumor suppressor. Here, we studied the role of Id2 in a well characterized model of ocular cancer in which the three pocket proteins are inactivated by generating mice lacking one or both Id2 alleles. Id2 deficiency had no impact on tumorigenesis in the eye. Unexpectedly, however, Id2 loss significantly increased the rate of metastasis. Liver metastases in Id2 heterozygotes demonstrated significant decrease of Id2 expression and loss of the remaining Id2 allele, strongly suggesting that Id2 inactivation specifically was required for metastasis in this model. These findings provide new insights into the role of Id2 in metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127274      PMCID: PMC4467556          DOI: 10.1007/s10585-010-9304-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

Authors:  Y Yokota; A Mansouri; S Mori; S Sugawara; S Adachi; S Nishikawa; P Gruss
Journal:  Nature       Date:  1999-02-25       Impact factor: 49.962

2.  Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins.

Authors:  X H Sun; N G Copeland; N A Jenkins; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

3.  Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.

Authors:  Anna Lasorella; Gerson Rothschild; Yoshifumi Yokota; Robert G Russell; Antonio Iavarone
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.

Authors:  T Ikawa; S Fujimoto; H Kawamoto; Y Katsura; Y Yokota
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium.

Authors:  Robert G Russell; Anna Lasorella; Luis E Dettin; Antonio Iavarone
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

6.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.

Authors:  A Lasorella; M Noseda; M Beyna; Y Yokota; A Iavarone
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

7.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  Survival in patients with uveal melanoma in Europe.

Authors:  Gianni Virgili; Gemma Gatta; Laura Ciccolallo; Riccardo Capocaccia; Annibale Biggeri; Emanuele Crocetti; Jean-Michel Lutz; Eugenio Paci
Journal:  Arch Ophthalmol       Date:  2008-10

9.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.

Authors:  Marcin Kowanetz; Ulrich Valcourt; Rosita Bergström; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more
  4 in total

Review 1.  Networks modulating the retinal response to injury: insights from microarrays, expression genetics, and bioinformatics.

Authors:  Félix R Vázquez-Chona; Eldon E Geisert
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.

Authors:  Rosaria Gangemi; Valentina Mirisola; Gaia Barisione; Marina Fabbi; Antonella Brizzolara; Francesco Lanza; Carlo Mosci; Sandra Salvi; Marina Gualco; Mauro Truini; Giovanna Angelini; Simona Boccardo; Michele Cilli; Irma Airoldi; Paola Queirolo; Martine J Jager; Antonio Daga; Ulrich Pfeffer; Silvano Ferrini
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

3.  Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration.

Authors:  Jian-Ting Chen; Yuan-Ling Hsu; Yi-Chiung Hsu; Yi-Hsin Tseng; Ming-Han Liu; Chia-Wei Weng; Ching-Hao Lin; Szu-Hua Pan; Jeremy J W Chen; Chi-Chung Wang
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

4.  Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells.

Authors:  Ti-Hui Wu; Shan-Yueh Chang; Yu-Lueng Shih; Chih-Feng Chian; Hung Chang; Ya-Wen Lin
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.